Therefore, methylation of the BNIP3 promoter in primary colon cancer may contribute to the impairment of MALM induction in vivo, leading to failure of the Mieap-regulated mitochondrial quality control function and accumulation of unhealthy mitochondria generating high levels of ROS in the tumor microenvironment. Here, BNIP3 is linked to neoplasm.